Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ONCOS-102 mesothelioma study published in Journal for ImmunoTherapy of Cancer

· ONCOS-102 combined with chemotherapy demonstrated 34.1% overall survival (OS) rate at 30 months in first line patients, compared to 0% in the chemotherapy-only group · ONCOS-102 promoted robust immune responses, including an association between T-cell infiltration and patient survival Oslo, Norway, 4 September 2023– Circio Holding ASA (OSE: CRNA), a biotechnology company developing novel circular RNA and immunotherapy medicines, today announces that the completed phase 1/2 trial of ONCOS-102 in combination with Standard of Care (SoC) chemotherapy in malignant pleural mesothelioma (

AbbVie’s AQUIPTA[®]▼(atogepant) receives MHRA marketing authorisation for the prevention of migraines in adults

PRESS RELEASE - For UK consumer, trade and medical media only · The oral, once-daily calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) is licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain for the prophylaxis of migraine in adults who have at least four migraine days per month.[1] · The marketing authorisation is based on results from two pivotal Phase 3 studies in which the treatment demonstrated significant reduction in mean monthly migraine days from baseline across 12 weeks.[1-5] · The news closely follows the European

Paradox Interactive Announces Vampire: The Masquerade – Bloodlines 2 is Back, in Development by The Chinese Room

Celebrated for their storytelling legacy, creators of critically-acclaimed titles bring more than 15 years of award-winning experience to World of DarknessSEATTLE – September 2, 2023 – Paradox Interactive announced that The Chinese Room , a Sumo Digital  studio, is developing the highly-anticipated Vampire: The Masquerade – Bloodlines 2 during today’s PAX West keynote. The Chinese Room brings their award-winning  storytelling to Bloodlines 2, creating a high-quality Vampire:

The Best Ways to Brighten Your Home’s Interior

Nobody likes the thought of a dull or dark home. It can seem gloomy, uncomfortable, and less inviting. Luckily, there are many things you can do to instantly brighten up your home's interior. From well-placed mirrors to choosing the right paint shades, it's easier than you may think to give your home a quick brightness boost.     Interior design expert Ryan McDonough at MyJobQuote.co.uk  has teamed up with several interiors experts to create this list of the best ways to brighten up your home’s interior. Take a look at the list below.

Nordea Bank Abp: Repurchase of own shares on 01.09.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares01.09.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 01.09.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |49,193 |10.15 |499,436.85

Total Voting Rights

01 September 2023   FIDELITY SPECIAL VALUES PLC   LEI: 549300XODK7D2K2KYV43     TOTAL NUMBER OF VOTING RIGHTS AND CAPITAL     This announcement is made in accordance with DTR 5.6.   During the month of August 2023, Fidelity Special Values PLC did not issue any ordinary shares.   No ordinary shares were repurchased into Treasury or for cancellation.   As at 31 August 2023, Fidelity Special Values PLC’s issued share capital consisted of 324,098,920 ordinary shares. There are no ordinary shares held in Treasury; therefore, the total number of

Total Voting Rights

01 September 2023   FIDELITY EUROPEAN TRUST PLC   LEI: 549300UC0QPP7Y0W8056     TOTAL NUMBER OF VOTING RIGHTS AND CAPITAL     This announcement is made in accordance with DTR 5.6.   During the month of August 2023, Fidelity European Trust PLC did not repurchase any ordinary shares into Treasury or for cancellation.   No ordinary shares were issued.   As at 31 August 2023, Fidelity European Trust PLC's issued share capital consisted of 416,447,910 ordinary shares. This figure also includes 7,717,387 ordinary shares held in Treasury, which

Total Voting Rights

01 September 2023   FIDELITY CHINA SPECIAL SITUATIONS PLC   LEI: 54930076MSJ0ZW67JB75     TOTAL NUMBER OF VOTING RIGHTS AND CAPITAL     This announcement is made in accordance with DTR 5.6.     During the month of August 2023, Fidelity China Special Situations PLC repurchased 1,486,921 ordinary shares for cancellation.   No ordinary shares were issued.   As at 31 August 2023, Fidelity China Special Situations PLC's issued share capital consisted of 565,415,408 ordinary shares. This figure also includes 85,629,548 ordinary shares held in

Total Voting Rights

01 September 2023   FIDELITY EMERGING MARKETS LIMITED (the ‘Company’)   Legal Entity Identifier (LEI): 213800HWWQPUJ4K1GS84   TOTAL NUMBER OF VOTING RIGHTS AND CAPITAL   In accordance with DTR 5.6.1 of the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, the Company would like to notify the market of the following:   During the month of August 2023, Fidelity Emerging Markets Limited did not issue any Participating Preference shares.   No Participating Preference shares were repurchased into Treasury or for cancellation.   As

Total Voting Rights

01 September 2023   FIDELITY ASIAN VALUES PLC   LEI: 54930094CXNYINSNOQ96     TOTAL NUMBER OF VOTING RIGHTS AND CAPITAL     This announcement is made in accordance with DTR 5.6.   During the month of August 2023, Fidelity Asian Values PLC did not repurchase any ordinary shares into Treasury or for cancellation.   No ordinary shares were issued.   As at 31 August 2023, Fidelity Asian Values PLC's issued share capital consisted of 75,580,889 ordinary shares. This figure also includes 3,751,553 ordinary shares held in Treasury, which attract no

Total Voting Rights

01 September 2023   FIDELITY JAPAN TRUST PLC   LEI: 549300ND695NEJ5GPI72     TOTAL NUMBER OF VOTING RIGHTS AND CAPITAL     This announcement is made in accordance with DTR 5.6.   During the month of August 2023, Fidelity Japan Trust PLC repurchased 267,500 ordinary shares into Treasury. No ordinary shares were repurchased for cancellation.   No ordinary shares were issued.   As at 31 August 2023, Fidelity Japan Trust PLC’s issued share capital consisted of 136,161,695 ordinary shares. This figure also includes 7,445,136 ordinary shares held in

Thapanee Kiatphaiboon began her role as new TAT Governor

1 September 2023 – Ms. Thapanee Kiatphaiboon today began her role as the new Governor of the Tourism Authority of Thailand (TAT).[A person in a suit Description automatically generated]   Having been with the TAT in 1999 after earning a master’s degree in science from the University of Surrey in the UK, Ms. Thapanee has held various positions within the organisation, including Deputy Governor for Tourism Products and Business, and most recently Deputy Governor for Domestic Marketing.   In her most recent role as TAT Deputy Governor for Domestic Marketing, Ms. Thapanee initiated

Transaction in Own Shares

FIDELITY JAPAN TRUST PLC TRANSACTION IN OWN SHARES The Board of Fidelity Japan Trust PLC ("the Company") announces that on 01 September 2023 the Company bought into Treasury 25,000 of its own shares at a price of 168.5000 pence per share.  The Company's issued ordinary share capital is 136,161,695 of which 7,470,136 shares are held in Treasury, which attract no voting rights. Therefore, the total number of voting rights in the Company is now 128,691,559. The above figure (128,691,559) may be used by shareholders as the denominator for the calculations by which they will

Elkem ASA - Buyback of shares

Oslo, 1 September 2023 Please see below information about transactions made under the share buyback programme for Elkem ASA. · Date on which the buyback programme was announced: 14 August 2023 · The duration of the buyback programme: 14 August 2023 to 8 September 2023 · Size of the buyback programme: Up to 2,000,000 shares From 26 August 2023 until 1 September 2023, Elkem ASA has purchased a total of 500,000 own shares at the Oslo Stock Exchange at an average price of NOK 21.8708 per share. Aggregated overview of transactions per day: Date Aggregated

DNB Bank ASA – status of share buy-back programme after week 35 2023

On 17 July 2023, DNB Bank ASA (“DNB”) announced that the company has decided to initiate a share buy-back programme comprising up to 1.5 percent of the company’s own shares, which represents a total of 23,139,197 shares.  Up to 15,271,870 shares will be bought back on trading venues by 18 October 2023, and a proposal will be made at the Annual General Meeting in 2024 to cancel the shares. At the same meeting it will also be proposed to redeem the remaining shares – up to 7,867,327 shares – from the Norwegian Government, represented by the Ministry of Trade, Industry and Fisheries (“NFD”),

Bittium Corporation: SHARE REPURCHASE 1.9.2023

Bittium Corporation  ANNOUNCEMENT  1.9.2023 Bittium Corporation: SHARE REPURCHASE 1.9.2023 In the Helsinki Stock Exchange Trade date           1.9.2023Bourse trade         BuyShare                  BITTIAmount             1 500 SharesAverage price/ share    4,1000 EURTotal cost            6 150,00 EUR Bittium Corporation now holds a total of 163 429 sharesincluding the shares repurchased on 1.9.2023 On behalf of Bittium Corporation Nordea Bank Oyj

AAK's Chairman of the Board, Georg Brunstam, has passed away

Press release, September 1, 2023 AAK has been reached by the deeply saddening notice that its Chairman, Georg Brunstam, has passed away. Elected as Chairman in 2018, Georg Brunstam's dedication and vision have been essential in the journey of AAK. In the interim, the Board will appoint a Chairman among its current members until a new Chairman has been elected by the General Meeting. Johan Westman, CEO of AAK: “Georg will be remembered as a warm, highly ethical and assertive leader with exceptional business acumen.” Our thoughts and heartfelt condolences are extended to Georg's

#23-281 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Total Voting Rights

1 September 2023 15:00 BST Transparency DirectiveVoting rights and capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 August 2023 the issued share capital of AstraZeneca PLC with voting rights is 1,549,897,364 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,549,897,364. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they

HEXPOL´s CEO and President, Georg Brunstam, has suddenly passed away

“It is with great shock and grief that we have received this sad notification”, says Alf Göransson, Chairman of HEXPOL AB (publ.). Georg Brunstam joined HEXPOL as CEO and President in 2008 and has since, both in the role as CEO but also during a period as Chairman of the Board, with great success developed HEXPOL into a world-leading player in the market of polymer compounds. “Georg will be deeply missed within HEXPOL, both on a personal and on a professional level. Georg has created a strong organization with many highly skilled and qualified managers. The Board of Directors is now

Vector Photonics collaborates with Sivers Photonics to evaluate new material for next-generation lasers

Sivers Semiconductors AB ("Sivers"; Nasdaq Stockholm: OM. SIVE) subsidiary Sivers Photonics has received an initial order from Vector Photonics for the evaluation of epitaxial material for a new, next-generation surface coupling laser project. The order, which includes laser fabrication and life testing, will be the first time both Glasgow-based companies have worked together on a collaborative project, and it will be manufactured on the Sivers InP100 platform at their advanced Glasgow foundry. The project is at the forefront of global laser technology development, and the collaboration with

Introducing BioGaia Prodentis KIDS in Sweden

BioGaia introduces Prodentis for kids, an apple-flavored lozenge with probiotics and xylitol for oral health, to complement the daily toothbrushing routine. A new addition to the oral health category.Most kids enjoy snacking in between meals, often prefer sugary foods, and have varying enthusiasm for toothbrushing. These habits can lead to unhealthy oral hygiene. Prodentis KIDS contains BioGaia’s patented clinically proven probiotic strains L. reuteri ATCC PTA 5289 and L. reuteri DSM 17938 that help the good microorganisms keep a natural balance in the mouth. Prodentis KIDS is specially

There are no items matching the current filter
There are no more items matching the current filter
Back to top